Cargando…
The effect of Epstein–Barr virus viremia on the progression to severe COVID-19
Epstein–Barr virus (EBV) is frequently reactivated by coronavirus 2019 (COVID-19), and a high incidence of EBV viremia has been reported in patients with severe COVID-19. However, the impact of EBV viremia on progression to severe COVID-19 is unclear. Therefore, we conducted a study to evaluate the...
Autores principales: | Im, Jae Hyoung, Nahm, Chung Hyun, Je, Young Soo, Lee, Jin-Soo, Baek, Ji Hyeon, Kwon, Hea Yoon, Chung, Moon-Hyun, Jang, Ji-Hun, Kim, Jung Soo, Lim, Jun Hyeok, Park, Mi Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276369/ https://www.ncbi.nlm.nih.gov/pubmed/35550458 http://dx.doi.org/10.1097/MD.0000000000029027 |
Ejemplares similares
-
Effect of a serum lactate monitoring recommendation policy on patients treated with linezolid
por: Im, Jae Hyoung, et al.
Publicado: (2021) -
Chryseobacterium arthrosphaerae ventriculitis: A case report
por: Im, Jae Hyoung, et al.
Publicado: (2020) -
Medical management of septic arthritis of sternoclavicular joint: A case report
por: Kwon, Hea Yoon, et al.
Publicado: (2020) -
Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers
por: Lee, Dong Yeop, et al.
Publicado: (2023) -
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
por: Im, Jae Hyoung, et al.
Publicado: (2020)